Comparative effectiveness of a second-line biologic in patients with ulcerative colitis: vedolizumab followed by an anti-TNF versus anti-TNF followed by vedolizumab.
第一作者:
Charles,Miller
第一单位:
Department of Gastroenterology, University College Hospital, London, UK.
作者:
DOI
10.1136/flgastro-2021-101906
PMID
36051959
发布时间
2023-01-08
- 浏览0
Frontline gastroenterology
392-401页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文


换一批



